Skip to search formSkip to main contentSkip to account menu

lidamycin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
DNA repair enables tumor cells to survive from DNA damage induced by chemotherapeutic treatments or ionizing radiation (IR), and… 
2013
2013
Objective To investigate the effect of Lidamycin(LDM) against mouse myeloma in vivo and in vitro and provide the basis for its… 
2012
2012
Objective: To observe the regulation action of salidroside on cellular senescence of human fetal lung fibroblasts 2BS cells… 
2010
2010
Objective:AtrA (AtrA-c) was characterized as a transcriptional activator for actII-ORF4 gene which encoding a pathway-specific… 
2008
2008
Objective:To set up methods of fluorescence derivatization of lidamycin apoprotein.Method:Amino groups and car- boxyl groups of… 
2007
2007
This study is to investigate the antitumor activities of the immunoconjugates composed of anti-type IV collagenase monoclonal… 
2005
2005
AIM: To investigate the tissue distribution, urinary and fecal excretions of 125I-lidamycin (125I-C-1027) in mice and its biliary… 
2004
2004
Objective To study the in vitro and in vivo antitumor effect of lidamycin on hepatoma.Methods MTT assay was used to determine the… 
2004
2004
Objective:To define potency unit of lidamycin and establish the potency determination method. Methods : The potency of primary… 
2000
2000
AIM To develop a novel, highly potent antitumor immunoconjugate of smaller molecular size by linking lidamycin (also called C1027…